| Factor Information | |
|---|---|
| Data ID | 2687 |
| Factor | CC (Z score) (physical sizes at birth) |
| Description | Next we compared physical sizes at birth between CHD and control groups using Z scores. Although the HC of newborns with CHD was similar to that of the control group, BW, BL and CC of the CHD group were significantly more restricted than those of the control group. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Our aim was to investigate the association between fetal growth and cerebrovascular resistance in fetuses with congenital heart disease (CHD). |
| p Value | 0.0007 |
| Conclusion | Next we compared physical sizes at birth between CHD and control groups using Z scores. Although the HC of newborns with CHD was similar to that of the control group, BW, BL and CC of the CHD group were significantly more restricted than those of the control group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 614 |
| CHD Type | isolated CHD |
| CHD Subtype | PA/PS/HLHS/IAA/HRV/TA/TOF/EA/DORV/SV/TGA/TA/VSD/other |
| Reference | |
|---|---|
| PMID | 21849766 |
| Year | 2011 |
| Title | Changes in fetal circulation associated with congenital heart disease and their effects on fetal growth |
| Sample | ||
|---|---|---|
| Population | fetuses | |
| Source | database | |
| Region | Niigata, Japan | |
| Method | This retrospective study included subjects identified through the database of our department. All data were obtained from medical records. | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD(Treatment) | Control(Control) |
| Number | 43 | 140 |
| Age | 30+4 (28+0 to 34+0) weeks | 30+1 (28+3 to 33+1) weeks |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | –0.39 (–2.25 to 2.00) | 0.29 (–1.14 to 2.14) |
